Verition Fund Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.1K | Buy |
+13,345
| New | +$98.1K | ﹤0.01% | 2747 |
|
|
2021
Q3 | – | Sell |
-51,613
| Closed | -$1.68M | – | 1816 |
|
|
2021
Q2 | $1.68M | Buy |
51,613
+14,039
| +37% | +$456K | 0.02% | 504 |
|
|
2021
Q1 | $1.42M | Sell |
37,574
-2,677
| -7% | -$101K | 0.02% | 421 |
|
|
2020
Q4 | $1.91M | Buy |
+40,251
| New | +$1.91M | 0.02% | 306 |
|